| Hong Chen, MD | |
|
400 N Pleasant Ave, Centralia, IL 62801-3056 | |
| (618) 436-5034 | |
| Not Available |
| Full Name | Hong Chen |
|---|---|
| Gender | Female |
| Speciality | Pathology |
| Experience | 40 Years |
| Location | 400 N Pleasant Ave, Centralia, Illinois |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023087152 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ssm Health - Good Samaritan Hospital | Mount vernon, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Physician Services Corporation Of Southern Illinois Inc | 9234022567 | 109 |
| Ssm Health Care Group | 0143608372 | 678 |
News Archive
Thommen Medical, a leading Swiss company in the area of the oral implantology, will officially launch the latest products in the evolution of implant surface technology, APLIQUIQ and INICELL, at the 2009 AAOMS Meeting in Toronto, Canada.
W. L. Gore & Associates joined with leaders from across the vascular and endovascular community to honor a distinguished group of eight physicians receiving the 2010 Pioneers in Performance Awards.
Ranbaxy Laboratories Limited (RLL), has announced that the Company has received final approval from the U.S. Food and Drug Administration to manufacture and market Zolpidem Tartrate Tablets, 5mg and 10mg.
More than a billion people worldwide suffer from high blood pressure (hypertension). Prolonged hypertension damages blood vessels, which can result in damage to the heart, the kidneys, and the brain. Possible consequences include heart attack, kidney failure, and stroke.
› Verified 4 days ago
| Entity Name | Physician Services Corporation Of Southern Illinois Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831101807 PECOS PAC ID: 9234022567 Enrollment ID: O20040304000583 |
News Archive
Thommen Medical, a leading Swiss company in the area of the oral implantology, will officially launch the latest products in the evolution of implant surface technology, APLIQUIQ and INICELL, at the 2009 AAOMS Meeting in Toronto, Canada.
W. L. Gore & Associates joined with leaders from across the vascular and endovascular community to honor a distinguished group of eight physicians receiving the 2010 Pioneers in Performance Awards.
Ranbaxy Laboratories Limited (RLL), has announced that the Company has received final approval from the U.S. Food and Drug Administration to manufacture and market Zolpidem Tartrate Tablets, 5mg and 10mg.
More than a billion people worldwide suffer from high blood pressure (hypertension). Prolonged hypertension damages blood vessels, which can result in damage to the heart, the kidneys, and the brain. Possible consequences include heart attack, kidney failure, and stroke.
› Verified 4 days ago
| Entity Name | Ssm Health Care Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306589544 PECOS PAC ID: 0143608372 Enrollment ID: O20220606001320 |
News Archive
Thommen Medical, a leading Swiss company in the area of the oral implantology, will officially launch the latest products in the evolution of implant surface technology, APLIQUIQ and INICELL, at the 2009 AAOMS Meeting in Toronto, Canada.
W. L. Gore & Associates joined with leaders from across the vascular and endovascular community to honor a distinguished group of eight physicians receiving the 2010 Pioneers in Performance Awards.
Ranbaxy Laboratories Limited (RLL), has announced that the Company has received final approval from the U.S. Food and Drug Administration to manufacture and market Zolpidem Tartrate Tablets, 5mg and 10mg.
More than a billion people worldwide suffer from high blood pressure (hypertension). Prolonged hypertension damages blood vessels, which can result in damage to the heart, the kidneys, and the brain. Possible consequences include heart attack, kidney failure, and stroke.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Hong Chen, MD 9 Clearlake Dr, Centralia, IL 62801-3720 Ph: (618) 532-7881 | Hong Chen, MD 400 N Pleasant Ave, Centralia, IL 62801-3056 Ph: (618) 436-5034 |
News Archive
Thommen Medical, a leading Swiss company in the area of the oral implantology, will officially launch the latest products in the evolution of implant surface technology, APLIQUIQ and INICELL, at the 2009 AAOMS Meeting in Toronto, Canada.
W. L. Gore & Associates joined with leaders from across the vascular and endovascular community to honor a distinguished group of eight physicians receiving the 2010 Pioneers in Performance Awards.
Ranbaxy Laboratories Limited (RLL), has announced that the Company has received final approval from the U.S. Food and Drug Administration to manufacture and market Zolpidem Tartrate Tablets, 5mg and 10mg.
More than a billion people worldwide suffer from high blood pressure (hypertension). Prolonged hypertension damages blood vessels, which can result in damage to the heart, the kidneys, and the brain. Possible consequences include heart attack, kidney failure, and stroke.
› Verified 4 days ago